MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Loxo Oncology Company Profile (NASDAQ:LOXO)

Consensus Ratings for Loxo Oncology (NASDAQ:LOXO) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $24.50 (17.68% upside)

Analysts' Ratings History for Loxo Oncology (NASDAQ:LOXO)
Show:
DateFirmActionRatingPrice TargetActions
8/27/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015OppenheimerReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Stifel NicolausBoost Price TargetBuy$20.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015OppenheimerSet Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Leerink SwannInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014OppenheimerInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Stifel NicolausInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2014JMP SecuritiesInitiated CoverageOutperform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha